Quinazolinedione sulfonamides: A novel class of competitive AMPA receptor antagonists with oral activity.
Koller, M., Lingenhoehl, K., Schmutz, M., Vranesic, I.T., Kallen, J., Auberson, Y.P., Carcache, D.A., Mattes, H., Ofner, S., Orain, D., Urwyler, S.(2011) Bioorg Med Chem Lett 21: 3358-3361
- PubMed: 21531559 
- DOI: https://doi.org/10.1016/j.bmcl.2011.04.017
- Primary Citation of Related Structures:  
3R7X - PubMed Abstract: 
Quinazoline-2,4-diones with a sulfonamide group attached to the N(3) ring atom constitute a novel class of competitive AMPA receptor antagonists. One of the synthesized compounds, 28, shows nanomolar receptor affinity, whereas other examples of the series display oral anticonvulsant activity in animal models.
Organizational Affiliation: 
Novartis Institutes for BioMedical Research, Global Discovery Chemistry, 4002 Basel, Switzerland. manuel.koller@novartis.com